Budesonide

BreastfeedingPediatric
  • TRADE NAMES: Pulmicort Turbuhaler (AstraZeneca); Rhinocort (AstraZeneca); Symbicort (AstraZeneca)
  • INDICATIONS: Asthma, rhinitis
  • CLASS: Corticosteroid, inhaled
  • HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Boceprevir, Efavirenz, Itraconazole, Ketoconazole, Live vaccines, Oral Contraceptives, Telaprevir

PREGNANCY CATEGORY: C

Symbicort is budesonide and formoterol.

Our database has 59 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
NEUROMUSCULAR/SKELETAL
OCULAR
RESPIRATORY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of budesonide MMX in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 11/23/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top